Zhouxiao Li
Novartis (Switzerland)(CH)Nanchang Institute of Technology(CN)Sun Yat-sen University(CN)Chinese Academy of Sciences(CN)Huawei Technologies (China)(CN)Nanfang Hospital(CN)Beijing National Laboratory for Molecular Sciences(CN)Zoucheng People's Hospital(CN)University of Chinese Academy of Sciences(CN)First Affiliated Hospital Zhejiang University(CN)Southern Medical University(CN)China National Petroleum Corporation (China)(CN)
Publications by Year
Research Areas
Cancer Immunotherapy and Biomarkers, Lung Cancer Treatments and Mutations, Circular RNAs in diseases, MicroRNA in disease regulation, Cancer-related molecular mechanisms research
Most-Cited Works
- → An emerging function of circRNA-miRNAs-mRNA axis in human diseases(2017)546 cited
- → Artificial Intelligence in Dermatology Image Analysis: Current Developments and Future Trends(2022)205 cited
- → LBA8_PR Pembrolizumab plus chemotherapy versus chemotherapy as first-line therapy in patients with advanced esophageal cancer: The phase 3 KEYNOTE-590 study(2020)130 cited
- → Single-cell RNA sequencing in cancer: Applications, advances, and emerging challenges(2021)91 cited
- → Role of Small Molecule Targeted Compounds in Cancer: Progress, Opportunities, and Challenges(2021)88 cited
- → Validation of two handheld devices against a non-portable three-dimensional surface scanner and assessment of potential use for intraoperative facial imaging(2019)70 cited